TODD STRATEGY GROUP

Lobbying for VAXART INC. · Clinical-stage biotechnology company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Vaccine policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem